Active Site Topology of Human Cytochrome P450 2E1

1996 ◽  
Vol 9 (1) ◽  
pp. 223-226 ◽  
Author(s):  
Richard Mackman ◽  
Zuyu Guo ◽  
F. Peter Guengerich ◽  
Paul R. Ortiz de Montellano
2005 ◽  
Vol 28 (7) ◽  
pp. 1221-1223 ◽  
Author(s):  
Yohei Ohashi ◽  
Katsuya Yamada ◽  
Ikuyo Takemoto ◽  
Takaharu Mizutani ◽  
Ken-ichi Saeki

2014 ◽  
Vol 219 ◽  
pp. 195-202 ◽  
Author(s):  
Suneel K. Kandagatla ◽  
Todd Mack ◽  
Sean Simpson ◽  
Jill Sollenberger ◽  
Eric Helton ◽  
...  

2010 ◽  
Vol 82 (12) ◽  
pp. 5357-5362 ◽  
Author(s):  
Lok Hang Mak ◽  
Sheila J. Sadeghi ◽  
Andrea Fantuzzi ◽  
Gianfranco Gilardi

Author(s):  
Wolfgang A. Schmalix ◽  
Martina Barrenscheen ◽  
Robert Landsiedel ◽  
Christine Janzowski ◽  
Gerhard Eisenbrand ◽  
...  

2014 ◽  
Vol 60 (5) ◽  
pp. 528-537 ◽  
Author(s):  
L.A. Kaluzhskiy ◽  
O.V. Gnedenko ◽  
A.A. Gilep ◽  
N.V. Strushkevich ◽  
T.V. Shkel ◽  
...  

The cholesterol biosynthesis regulation is the important part of the hypercholesterolemia diseases therapy. The inhibition of the post-squalene cholesterol biosynthesis steps provide the alternative to classic statin therapy. Sterol-14a-demethylase (CYP51) is one of the hypothetical targets for it. In this work the screening of the ability to interact with human CYP51 (CYP51A1) for the nature low-weight compounds with steroid-like scaffold were performed by integration of the surface plasmon resonance biosensor and spectral titration methods. The results of the selection were 4 compounds (betulafolientriol, holothurin A, teasaponin, capsicoside A) witch had high affinity to the CYP51A1 active site. These data extend the range of compounds which may be used as specific inhibitors of CYP51 and give the permission to suggest the dynamic of the enzyme.


Sign in / Sign up

Export Citation Format

Share Document